1. Home
  2. IQV vs FANG Comparison

IQV vs FANG Comparison

Compare IQV & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • FANG
  • Stock Information
  • Founded
  • IQV 1982
  • FANG 2007
  • Country
  • IQV United States
  • FANG United States
  • Employees
  • IQV N/A
  • FANG N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • FANG Oil & Gas Production
  • Sector
  • IQV Health Care
  • FANG Energy
  • Exchange
  • IQV Nasdaq
  • FANG Nasdaq
  • Market Cap
  • IQV 31.6B
  • FANG 37.4B
  • IPO Year
  • IQV 2013
  • FANG 2012
  • Fundamental
  • Price
  • IQV $150.19
  • FANG $136.76
  • Analyst Decision
  • IQV Buy
  • FANG Buy
  • Analyst Count
  • IQV 20
  • FANG 21
  • Target Price
  • IQV $236.75
  • FANG $200.24
  • AVG Volume (30 Days)
  • IQV 2.4M
  • FANG 2.9M
  • Earning Date
  • IQV 05-06-2025
  • FANG 05-05-2025
  • Dividend Yield
  • IQV N/A
  • FANG 4.54%
  • EPS Growth
  • IQV 2.74
  • FANG N/A
  • EPS
  • IQV 7.49
  • FANG 15.53
  • Revenue
  • IQV $15,405,000,000.00
  • FANG $10,561,000,000.00
  • Revenue This Year
  • IQV $4.08
  • FANG $42.56
  • Revenue Next Year
  • IQV $5.88
  • FANG N/A
  • P/E Ratio
  • IQV $20.03
  • FANG $8.81
  • Revenue Growth
  • IQV 2.81
  • FANG 32.69
  • 52 Week Low
  • IQV $135.97
  • FANG $114.00
  • 52 Week High
  • IQV $252.88
  • FANG $214.50
  • Technical
  • Relative Strength Index (RSI)
  • IQV 40.77
  • FANG 47.31
  • Support Level
  • IQV $137.49
  • FANG $130.32
  • Resistance Level
  • IQV $154.17
  • FANG $140.00
  • Average True Range (ATR)
  • IQV 8.48
  • FANG 7.59
  • MACD
  • IQV 1.00
  • FANG 1.21
  • Stochastic Oscillator
  • IQV 58.37
  • FANG 87.54

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About FANG Diamondback Energy Inc.

Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2024, the company reported net proven reserves of 3.6 billion barrels of oil equivalent. Net production averaged about 598,000 barrels per day in 2024, at a ratio of 56% oil, 23% natural gas liquids, and 21% natural gas.

Share on Social Networks: